Lateral flow tests have all the hallmarks of a quality diagnostic test.
Fast-acting and versatile, they can be used at the point of care with or without a reader, meaning that they’re easy to use, require little training and are easily deployed in any location.
This extraordinary technology is an area where Mologic are continuing to make huge advances.
Speaking with Paul Davis, Co-founder and Chief Scientific Officer at Mologic, it was fascinating to hear what he had to say on the next steps for lateral flow. How could we improve this beautifully simple technology?
Spencer talks to to Vered Caplan, CEO at Orgenesis Inc. about how their Point Of Care (POC) Platform aims to shape the Cell and Gene Therapies (CGT) ecosystem and market. Click here to listen.
As the Theranos and Holmes trial finally comes to a close, what has been the effect of the CEO’s 15 years of fraudulent tenure on the diagnostics industry?
In this episode of CM Conversations, our guest share his tips on hitting the ground running and building a team remotely, as well as the importance of investing in relationships. In his words, you should always be visible and available.